Risk of venous thromboembolism in patients infected with HIV: A cohort study

International Journal of Angiology

Volumn 22, Issue 2, 2013, Pages 95-100

  Sule, Ashishanil ^a   Pandit, Nihar ^a   Handa, Pankaj ^a   Chadachan, Veerandra ^a   Tan, Endean ^a   Sum, Faithnadine Choo Yun ^b   Joyce, Erhui Ling ^b   Chin, Tayjam ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b Raffles Girls' School (Secondary)   (Singapore)

Author keywords

anticoagulation; antithrombin 3; duplex; enoxaparin; homocysteine; protein C; protein S; risk factors

Indexed keywords

ANTITHROMBIN III; CARDIOLIPIN ANTIBODY; ENOXAPARIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL; WARFARIN;

ADULT; AMINO ACID BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ANTITHROMBIN III DEFICIENCY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; DRUG EFFICACY; EXTERNAL ILIAC THROMBOSIS; FEMORAL THROMBOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEG THROMBOSIS; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; LYMPHOMA; MALE; PNEUMOCYSTIS PNEUMONIA; POPLITEAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN S DEFICIENCY; RISK ASSESSMENT; RISK FACTOR; SUPERFICIAL THROMBOSIS; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; TUBERCULOSIS; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84878380597     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0033-1333866     Document Type: Article

References (21)

1. Bibas M., Biava G., Antinori A. HIV-Associated Venous Thromboembolism. Mediterr J Hematol Infect Dis: 2011; 3 1 e2011030
2. Ahonkhai A. A., Gebo K. A., Streiff M. B., Moore R. D., Segal J. B. Venous thromboembolism in patients with HIV/AIDS: a case-control study. J Acquir Immune Defic Syndr: 2008; 48 3 310 314
3. Klein S. K., Slim E. J., de Kruif M. D., et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med: 2005; 63 4 129 136
4. Saif M. W., Greenberg B. HIV and thrombosis: a review. AIDS Patient Care STDS: 2001; 15 1 15 24
5. Lijfering W. M., Sprenger H. G., Georg R. R., van der Meulen P. A., van der Meer J. Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection. Clin Chem: 2008; 54 7 1226 1233
6. Jacobson M. C., Dezube B. J., Aboulafia D. M. Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series. Clin Infect Dis: 2004; 39 1214 1222
7. Shen Y. M., Frenkel E. P. Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost: 2004; 10 3 277 280
8. Crum-Cianflone N. F., Weekes J., Bavaro M. Thromboses among HIV-infected patients during the HAART era. AIDS Patient Care STDS: 2008; 22 10 771 778
9. Orlovic D., Smego R. A. Hypercoagulability due to protein S deficiency in HIV-seropositive patients. Int J Collab Res Inter Med Public Health: 2009; 1 6-7 187 193
10. Stahl C. P., Wideman C. S., Spira T. J., Haff E. C., Hixon G. J., Evatt B. L. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood: 1993; 81 7 1801 1807
11. Erbe M., Rickerts V., Bauersachs R. M., Lindhoff-Last E. Acquired protein C and protein S deficiency in HIV-infected patients. Clin Appl Thromb Hemost: 2003; 9 4 325 331
12. Parruti G., Manzoli L., Di Iorio G., et al. Plasma homocysteine levels in an Italian cohort of HIV infected patients. International AIDS society 2012; The 3rd IAS Conference on HIV Pathogenesis and Treatment; Abstract no. 2177530
13. Brey R. L., Arroyo R., Boswell R. N. Cerebrospinal fluid anti-cardiolipin antibodies in patients with HIV-1 infection. J Acquir Immune Defic Syndr: 1991; 4 4 435 441
14. Maclean C., Flegg P. J., Kilpatrick D. C. Anti-cardiolipin antibodies and HIV infection. Clin Exp Immunol: 1990; 81 2 263 266
15. Coll Daroca J., Gutiérrez-Cebollada J., Yazbeck H., Bergés A., Rubiés-Prat J. Anticardiolipin antibodies and acquired immunodeficiency syndrome: prognostic marker or association with HIV infection? Infection: 1992; 20 3 140 142
16. Love P. E., Santoro S. A. Antiphospholipid antibodies; anticardiolipin and the lupus anticoagulant in systemic lupus erthematosus (SLE) and in non-SLE disorders. Ann Intern Med: 1990; 2 682 698
17. Viscarello R. R., Williams C. J., DeGennaro N. J., Hobbins J. C. Prevalence and prognostic significance of anticardiolipin antibodies in pregnancies complicated by human immunodeficiency virus-1 infection. Am J Obstet Gynecol: 1992; 167 4, Pt 1 1080 1085
18. Barbaro G. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection. Curr HIV Res: 2006; 4 1 79 85
19. Koppel K., Bratt G., Schulman S., Bylund H., Sandström E. Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy. J Acquir Immune Defic Syndr: 2002; 29 5 441 449
20. Majluf-Cruz A., Silva-Estrada M., Sánchez-Barboza R., et al. Venous thrombosis among patients with AIDS. Clin Appl Thromb Hemost: 2004; 10 1 19 25
21. Goldstein K. M., Gluckman S., Mounzer K. Challenge of coadministering antiretroviral therapy and oral anticoagulants in HIV-positive patients. AIDS Read: 2008; 18 9 480 482, 486-489